HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 04 03 2020
revised: 01 04 2020
accepted: 11 04 2020
pubmed: 21 4 2020
medline: 9 3 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

The development of donor specific antibody is associated with graft rejection and increased mortality in solid organ transplant recipients. The majority of de novo donor specific antibodies (dnDSA) are against HLA-DQ antigens, but it has not been investigated if this is caused by more mismatches in the HLA-DQ locus between the recipient and donor. Here we examined the impact of HLA mismatches in eight HLA loci on the development of dnDSA and on rejection in a large cohort of heart transplant recipients. We evaluated HLA mismatches at the antigen level, the eplet level using HLAMatchmaker, and the epitope level using the PIRCHE algorithm. We found that the majority of dnDSA were against HLA-DQ antigens, and the number of dnDSA per mismatch is highest for HLA-DQ compared to other HLA loci. Furthermore, mismatches of HLA-DQ at the epitope level were associated with antibody-mediated rejection. Our results suggest that HLA mismatches at the HLA-DQ locus are more immunogenic than mismatches at other HLA loci to stimulate the development of dnDSA and to cause graft rejection.

Identifiants

pubmed: 32307126
pii: S0198-8859(20)30149-X
doi: 10.1016/j.humimm.2020.04.003
pii:
doi:

Substances chimiques

Epitopes 0
HLA-DQ Antigens 0
Immunosuppressive Agents 0
Isoantibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-336

Informations de copyright

Copyright © 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Auteurs

Xiaohai Zhang (X)

HLA Laboratory, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States. Electronic address: xiaohai.zhang@cshs.org.

Evan Kransdorf (E)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Ryan Levine (R)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Jignesh K Patel (JK)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Jon A Kobashigawa (JA)

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH